Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Over the last 12 months, insiders at Agilent Technologies, Inc. have bought $0 and sold $25.01M worth of Agilent Technologies, Inc. stock.
On average, over the past 5 years, insiders at Agilent Technologies, Inc. have bought $3,875 and sold $32.07M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 0 shares for transaction amount of $0 was made by Gonsalves Rodney (V.P., Corporate Controller) on 2023‑09‑28.
2024-06-18 | Sale | MCDONNELL PADRAIG | President and CEO | 1,958 0.0007% | $135.00 | $264,330 | -0.69% | |
2024-06-10 | Sale | Grau Dominique | Senior Vice President | 15,000 0.0052% | $133.28 | $2M | -0.06% | |
2024-06-03 | Sale | MCDONNELL PADRAIG | President and CEO | 1,958 0.0007% | $130.00 | $254,540 | +1.21% | |
2024-03-25 | Sale | Binns Philip | Senior Vice President | 2,827 0.001% | $147.54 | $417,096 | -4.10% | |
2024-03-08 | Sale | McMullen Michael R. | CEO and President | 52,297 0.018% | $150.00 | $7.84M | -3.89% | |
2024-03-07 | Sale | Gonsalves Rodney | V.P., Corporate Controller | 4,828 0.0016% | $149.00 | $719,348 | -4.30% | |
2024-03-05 | Sale | FIELDS HEIDI | director | 1,658 0.0006% | $144.34 | $239,316 | -0.43% | |
2023-12-27 | Sale | Binns Philip | Senior Vice President | 2,880 0.001% | $139.78 | $402,566 | -2.02% | |
2023-12-18 | Sale | Gonsalves Rodney | V.P., Corporate Controller | 1,500 0.0005% | $137.69 | $206,538 | -0.41% | |
2023-12-15 | Sale | Ancher-Jensen Henrik | Sr Vice President | 26,331 0.0091% | $138.36 | $3.64M | +0.59% | |
2023-12-13 | Sale | McMullen Michael R. | CEO and President | 2,751 0.0009% | $130.00 | $357,630 | +2.45% | |
2023-12-07 | Sale | McMullen Michael R. | CEO and President | 62,467 0.0215% | $130.00 | $8.12M | +6.27% | |
2023-09-28 | Gonsalves Rodney | V.P., Corporate Controller | 0 – | $0 | $0 | +18.72% | ||
2023-08-23 | Sale | Gonsalves Rodney | V.P., Corporate Controller | 3,500 0.0012% | $118.78 | $415,716 | +10.95% | |
2023-07-27 | Sale | McMullen Michael R. | CEO and President | 944 0.0003% | $130.00 | $122,720 | -7.77% | |
2022-12-14 | Sale | Ancher-Jensen Henrik | Sr Vice President | 29,500 0.01% | $155.78 | $4.6M | -17.37% | |
2022-12-13 | Sale | Grau Dominique | Senior Vice President | 4,000 0.0014% | $159.20 | $636,800 | -18.86% | |
2022-12-13 | Sale | MCDONNELL PADRAIG | Sr. Vice President | 672 0.0002% | $160.00 | $107,520 | -18.86% | |
2022-12-06 | Sale | KOH BOON HWEE | director | 13,000 0.0044% | $152.21 | $1.98M | -15.48% | |
2022-12-01 | Sale | Thaysen Jacob | Sr. Vice President | 3,235 0.0011% | $155.65 | $503,528 | -18.06% |
McMullen Michael R. | CEO and President | 253909 0.1045% | $133.09 | 0 | 57 | |
Grau Dominique | Senior Vice President | 49486 0.0315% | $133.09 | 0 | 25 | |
Ancher-Jensen Henrik | Sr Vice President | 82504 0.0282% | $133.09 | 0 | 3 | |
FIELDS HEIDI | director | 54976 0.0186% | $133.09 | 3 | 16 | +11.03% |
Gonsalves Rodney | V.P., Corporate Controller | 21329 0.0089% | $133.09 | 1 | 16 | |
MCDONNELL PADRAIG | Sr. Vice President | 28034 0.0053% | $133.09 | 0 | 9 | |
Binns Philip | Senior Vice President | 9997 0.0044% | $133.09 | 0 | 2 | |
SULLIVAN WILLIAM P | CEO | 458167 0.1564% | $133.09 | 0 | 15 | |
HIRSCH DIDIER | Sr. VP and CFO | 184851 0.0631% | $133.09 | 0 | 25 | |
Doak Mark | Sr. Vice President | 135678 0.0463% | $133.09 | 0 | 14 | |
DILLON ADRIAN T | EVP, Finance & Admin., CFO | 129925 0.0443% | $133.09 | 0 | 7 | |
Nersesian Ronald S. | Executive Vice President | 103733 0.0354% | $133.09 | 0 | 13 | |
CLARK PAUL N | director | 88857 0.0303% | $133.09 | 1 | 5 | +3.67% |
Roelofs Nicolas H PHD | Senior Vice President | 86527 0.0295% | $133.09 | 0 | 14 | |
Thaysen Jacob | Sr. Vice President | 84464 0.0288% | $133.09 | 0 | 7 | |
CULLEN JAMES | director | 76473 0.0261% | $133.09 | 1 | 9 | +3.67% |
HALLORAN JEAN | Senior Vice President | 74962 0.0256% | $133.09 | 0 | 10 | |
RAND A BARRY | director | 72842 0.0249% | $133.09 | 2 | 5 | +2.51% |
Kaltenbach Patrick | Sr Vice President | 68547 0.0234% | $133.09 | 0 | 17 | |
VAN INGEN CHRIS | Senior Vice President | 61340 0.0209% | $133.09 | 0 | 2 | |
KOH BOON HWEE | director | 57752 0.0197% | $133.09 | 1 | 8 | +3.67% |
BARNHOLT EDWARD W | 55829 0.0191% | $133.09 | 0 | 3 | ||
Raha Samraat S. | Sr. Vice President | 53936 0.0184% | $133.09 | 0 | 1 | |
HERBOLD ROBERT J | director | 47964 0.0164% | $133.09 | 2 | 6 | +6.75% |
Tang Michael | SVP, General Counsel, and Sec. | 46499 0.0159% | $133.09 | 0 | 19 | |
Huber Marie Oh | Sr VP, General Counsel & Sec. | 44772 0.0153% | $133.09 | 0 | 11 | |
LAWRENCE DAVID M | director | 39202 0.0134% | $133.09 | 1 | 5 | +3.67% |
NORDLUND D CRAIG | Sr VP, General Counsel & Sec. | 39101 0.0133% | $133.09 | 0 | 4 | |
Sene Guy | Senior Vice President | 32713 0.0112% | $133.09 | 0 | 4 | |
Strohmeier Fred | Senior Vice President | 25825 0.0088% | $133.09 | 0 | 1 | |
CHURCHILL DAVID S | Vice President | 21020 0.0072% | $133.09 | 0 | 1 | |
WHITE THOMAS | Senior Vice President | 15320 0.0052% | $133.09 | 0 | 3 | |
Odeh Saleem N. | Vice President | 15076 0.0051% | $133.09 | 0 | 2 | |
COOPER DAVID B JR | Senior Vice President | 15000 0.0051% | $133.09 | 2 | 0 | +11.14% |
Nelson Clark | EVP and CCO | 11778 0.004% | $133.09 | 1 | 0 | <0.0001% |
JOSS ROBERT L | director | 10528 0.0036% | $133.09 | 1 | 0 | +3.67% |
Glaize Solange | VP, Chief Accounting Officer | 5370 0.0018% | $133.09 | 0 | 2 | |
Gooi Soon Chai | Vice President | 4838 0.0017% | $133.09 | 0 | 1 |
The Vanguard Group | $4.35B | 10.2 | 29.88M | +18.22% | +$670.11M | 0.08 | |
BlackRock | $3.91B | 9.17 | 26.88M | -1.39% | -$55.18M | 0.09 | |
Massachusetts Financial Services Co Ma | $2.07B | 4.86 | 14.26M | +7.62% | +$146.82M | 0.62 | |
State Street | $1.84B | 4.33 | 12.68M | +0.33% | +$6M | 0.08 | |
T Rowe Price Investment Management Inc | $1.48B | 3.47 | 10.16M | +0.05% | +$675,311.94 | 0.9 | |
Wellington Management Company | $1.37B | 3.21 | 9.42M | -4.71% | -$67.81M | 0.23 | |
T. Rowe Price | $1.24B | 2.92 | 8.54M | +13.91% | +$151.76M | 0.15 | |
Geode Capital Management | $990.7M | 2.33 | 6.82M | +3.34% | +$32.01M | 0.09 | |
Morgan Stanley | $629M | 1.48 | 4.32M | -3.97% | -$26.03M | 0.05 | |
Deutsche Bank | $618.42M | 1.45 | 4.25M | +1.42% | +$8.64M | 0.28 | |
Northern Trust | $564.37M | 1.32 | 3.88M | -2.98% | -$17.33M | 0.1 | |
State Farm | $556.62M | 1.31 | 3.83M | 0% | +$0 | 0.5 | |
JPMorgan Chase | $522.06M | 1.22 | 3.59M | +12.84% | +$59.42M | 0.05 | |
Cantillon Capital Management LLC | $519.54M | 1.22 | 3.57M | -1.96% | -$10.39M | 3.27 | |
Brown Advisory | $446.95M | 1.05 | 3.07M | +33.96% | +$113.3M | 0.6 | |
Legal & General | $438.57M | 1.03 | 3.01M | -3.14% | -$14.2M | 0.1 | |
Nordea Investment Management Ab | $406.71M | 0.95 | 2.78M | +4.38% | +$17.07M | 0.48 | |
VanEck | $403.79M | 0.95 | 2.77M | +0.91% | +$3.66M | 0.62 | |
BNY Mellon | $367.02M | 0.86 | 2.52M | -4.85% | -$18.7M | 0.07 | |
Victory Capital Management Inc | $339.55M | 0.8 | 2.33M | -2.25% | -$7.8M | 0.35 | |
Bank of America | $334.89M | 0.79 | 2.3M | +19.89% | +$55.55M | 0.03 | |
Impax Asset Management Group | $330.51M | 0.78 | 2.27M | -3.93% | -$13.51M | 1.27 | |
Ubs Asset Management Americas Inc | $318.67M | 0.75 | 2.19M | -1.15% | -$3.71M | 0.11 | |
Ameriprise Financial | $317.51M | 0.75 | 2.18M | -3.9% | -$12.89M | 0.09 | |
Harris Associates | $317.26M | 0.74 | 2.18M | -6.92% | -$23.58M | 0.53 | |
Meritage Group LP | $315.19M | 0.74 | 2.17M | +2.33% | +$7.17M | 7.42 | |
American Century Investments | $305.86M | 0.72 | 2.1M | +4.03% | +$11.84M | 0.19 | |
PRIMECAP Management Co | $290.22M | 0.68 | 1.99M | -1.69% | -$5M | 0.22 | |
Goldman Sachs | $279.65M | 0.66 | 1.92M | -13.86% | -$44.98M | 0.05 | |
Franklin Templeton Investments | $279.71M | 0.66 | 1.92M | +1.04% | +$2.89M | 0.08 | |
Td Asset Management Inc | $260.66M | 0.61 | 1.79M | +11.31% | +$26.48M | 0.23 | |
Fidelity Investments | $252.99M | 0.59 | 1.74M | +5.39% | +$12.95M | 0.02 | |
Charles Schwab | $246.54M | 0.58 | 1.69M | +0.93% | +$2.26M | 0.06 | |
Invesco | $197.21M | 0.46 | 1.36M | -0.13% | -$254,642.42 | 0.04 | |
Nuveen | $193.69M | 0.45 | 1.33M | -2.01% | -$3.97M | 0.06 | |
Amundi | $168.12M | 0.43 | 1.27M | -17.61% | -$35.94M | 0.07 | |
Liontrust Investment Partners LLP | $178.74M | 0.42 | 1.23M | -3.31% | -$6.11M | 2.56 | |
RobecoSAM | $170.36M | 0.4 | 1.17M | -9.84% | -$18.58M | 2.97 | |
Macquarie Group | $169.63M | 0.4 | 1.17M | -8.4% | -$15.56M | 0.14 | |
Parnassus Investments Ca | $168.76M | 0.4 | 1.16M | -33.42% | -$84.72M | 0.36 | |
Bessemer Group Inc | $168.54M | 0.4 | 1.16M | -5.21% | -$9.27M | 0.31 | |
LGT Capital Partners | $165.42M | 0.39 | 1.14M | -15.56% | -$30.47M | 5.17 | |
Dimensional Fund Advisors | $143.99M | 0.34 | 989,564 | -4.16% | -$6.24M | 0.04 | |
Findlay Park Partners LLP | $142.64M | 0.34 | 980,310 | -14.86% | -$24.9M | 1.31 | |
Barclays | $140.86M | 0.33 | 968,007 | +20.94% | +$24.39M | 0.06 | |
Royal London Asset Management | $135.69M | 0.32 | 934,021 | -9.95% | -$14.99M | 0.34 | |
Panagora | $133.65M | 0.31 | 918,500 | -2.09% | -$2.85M | 0.67 | |
Saturna Capital | $132.52M | 0.31 | 910,694 | -0.03% | -$39,142.19 | 1.83 | |
HSBC | $131.96M | 0.31 | 907,321 | +19.5% | +$21.54M | 0.09 | |
William Blair Investment Management | $127.9M | 0.3 | 878,986 | +35.6% | +$33.58M | 0.33 |